About Pharming Group
Pharming Group is a company based in Leiden (Netherlands) founded in 1988.. Pharming Group has completed 2 acquisitions, including Abliva and DNage. Pharming Group offers products and services including Joenja. Pharming Group operates in a competitive market with competitors including Moderna, BridgeBio, Spark Therapeutics, Alnylam and ATAI, among others.
- Headquarter Leiden, Netherlands
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Pharming Group Nv
-
Annual Revenue
$285.45 M (USD)21.09as on Dec 31, 2024
-
Net Profit
$-11.38 M (USD)-12.2as on Dec 31, 2024
-
EBITDA
$7.09 M (USD)0as on Dec 31, 2024
-
Latest Funding Round
$139.1 M (USD), Post-IPO
Jan 14, 2020
-
Investors
HHS
& 5 more
-
Employee Count
Employee Count
-
Investments & Acquisitions
Abliva
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Pharming Group
Pharming Group is a publicly listed company on the EURONEXT with ticker symbol PHARM in Netherlands, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Pharming Group
Pharming Group offers a comprehensive portfolio of products and services, including Joenja. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Treatment for APDS rare disease through precision medicine.
Unlock access to complete
Unlock access to complete
Funding Insights of Pharming Group
- Total Funding Total Funding
- Total Rounds 7
- Last Round Post-IPO — $139.1M
- First Round First Round
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2020 | Amount | Post-IPO - Pharming Group | Valuation |
investors |
|
| May, 2017 | Amount | Post-IPO - Pharming Group | Valuation |
investors |
|
| Dec, 2016 | Amount | Post-IPO - Pharming Group | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Pharming Group
Pharming Group has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, Orbimed and Deerfield. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare ecosystem is supported through investment and innovation by Deerfield.
|
Founded Year | Domain | Location | |
|
Investment opportunities in healthcare are managed by Broadfin Capital.
|
Founded Year | Domain | Location | |
|
Sequoia Capital is engaged in venture capital investments.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Pharming Group
Pharming Group has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Abliva and DNage. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Therapies for DNA damage-related ageing diseases are developed.
|
2004 | ||||
|
Drugs are developed to treat multiple neurological disorders.
|
2000 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Pharming Group
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Pharming Group Comparisons
Competitors of Pharming Group
Pharming Group operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, BridgeBio, Spark Therapeutics, Alnylam and ATAI, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| domain | founded_year | HQ Location |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
|
| domain | founded_year | HQ Location |
RNA interference-based therapeutics are developed for multiple disorders.
|
|
| domain | founded_year | HQ Location |
A biopharmaceutical company accelerating innovative mental health treatments.
|
|
| domain | founded_year | HQ Location |
An AI-enabled platform is developed for infectious disease treatment.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Pharming Group
Frequently Asked Questions about Pharming Group
When was Pharming Group founded?
Pharming Group was founded in 1988 and raised its 1st funding round 7 years after it was founded.
Where is Pharming Group located?
Pharming Group is headquartered in Leiden, Netherlands. It is registered at Leiden, South Holland, Netherlands.
What is the annual revenue of Pharming Group?
Annual revenue of Pharming Group is $285.45M as on Dec 31, 2024.
What does Pharming Group do?
Pharming Group was founded in 1988 and is headquartered in Leiden, Netherlands. Focus is placed on the biotechnology sector, where recombinant protein-based therapeutics are developed for rare diseases. Operations include the production of Ruconest, a recombinant human C1 esterase inhibitor used in treating angioedema attacks. Additional therapies encompass enzyme replacement for Pompe disease, leniolisib for APDS, and rhC1INH for pre-eclampsia, acute kidney injury, and COVID-19.
Who are the top competitors of Pharming Group?
Pharming Group's top competitors include Moderna, Spark Therapeutics and BridgeBio.
What products or services does Pharming Group offer?
Pharming Group offers Joenja.
Is Pharming Group publicly traded?
Yes, Pharming Group is publicly traded on EURONEXT under the ticker symbol PHARM.
How many acquisitions has Pharming Group made?
Who are Pharming Group's investors?
Pharming Group has 6 investors. Key investors include HHS, Orbimed, Deerfield, Kingdon Capital Management, and Broadfin Capital.
What is Pharming Group's ticker symbol?
The ticker symbol of Pharming Group is PHARM on EURONEXT.